Cognition Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +21.0% | -5.1% | +152.7% | +7.2% | +5.6% | -14.3% | |
| – | +131,478.9% | +991.2% | -31.1% | +21.9% | -13.9% | -44.3% | |
| – | -32.4% | +1,077.0% | -25.1% | – | – | – | |
| – | +438.1% | -7.3% | -133.2% | – | -73.4% | -368.4% | |
| – | -93.1% | +170.0% | +533.3% | -14.0% | -97.3% | -100.0% | |
| – | -93.1% | +170.0% | +533.3% | -14.0% | -97.3% | – | |
| – | – | – | – | – | – | – | |
| – | +105.5% | -104.6% | +420.9% | -41.9% | -8.9% | -52.2% | |
| – | +106.3% | +822.8% | -89.6% | -18.5% | +421.2% | +55.2% | |
| – | – | +2,054.5% | -126.6% | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.